A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC).
Tai WM, Yong WP, Lim C, Low LS, Tham CK, Koh TS, Ng QS, Wang WW, Wang LZ, Hartono S, Thng CH, Huynh H, Lim KT, Toh HC, Goh BC, Choo SP.
Tai WM, et al. Among authors: hartono s.
Ann Oncol. 2018 Feb 1;29(2):526. doi: 10.1093/annonc/mdx060.
Ann Oncol. 2018.
PMID: 28368515
Free article.
No abstract available.